Match funding deal delivers new boost for historically
The Scottish Government and Prostate Cancer UK, with the support
of the Movember Foundation, have today (Wednesday 6 March)
announced a new six figure boost for research into prostate cancer,
the most common cancer in men in Scotland.
The money comes as part of a match-funding agreement between
Prostate Cancer UK and the Chief Scientist Office. The deal could
see up to £500,000 being pumped into prostate cancer research, with
Prostate Cancer UK topping up a £225,000 contribution from the
Scottish Government. The money will be used to fund clinical
research into detecting the differences between aggressive from
non-aggressive disease, one of Prostate Cancer UK's priority areas
for research funding.
The news, which comes during Prostate Cancer Awareness
Month, follows the recent announcement that Prostate Cancer UK
and the Movember Foundation have awarded £691,000 to researchers at
the universities of Glasgow, Strathclyde and Dundee.
The Scottish Government's contribution to today's £500,000
package was announced by Cabinet Secretary for Health and
Wellbeing, Alex Neil MSP, as experts gathered at Prostate Cancer
UK's Research Networking Conference at The Beatson Institute in
Cabinet Secretary for Health and Wellbeing, Alex Neil MSP, said:
"Prostate cancer is the most common cancer in men in Scotland and
the fourth most common cancer overall. Prostate cancers range from
slow-growing tumours to more aggressive tumours. Slow-growing
tumours are common and may not cause any symptoms or shorten life,
while aggressive tumours can be more difficult to treat.
"That is why Prostate Cancer UK and the Chief Scientist Office
of the Scottish Government have agreed to provide funding for
Scottish-led research projects that aim to advance knowledge of
prostate cancer. This represents an important collaboration between
the Scottish Government and Prostate Cancer UK in providing funding
for research into a disease that is a major cause of mortality
among men in Scotland."
In January figures published by Prostate Cancer UK showed that
breast cancer - the most common female cancer which has a similar
death rate as prostate cancer - received more than double the
annual research spend per case diagnosed in the UK (£853 compared
to £417 respectively).
Dr Iain Frame, Director of Research at Prostate Cancer UK, said:
"Due to decades of underfunding and neglect we still know far too
little about why prostate cancer kills one man in the UK every
hour. Working with our partners, the Movember Foundation, we have
recently been able to triple our research spend to a record
£25million over the next three years.
"Whilst incredibly proud to be making these investments we
remain acutely aware of how much more still needs to be done to get
prostate cancer research on a level footing with other cancers, and
crack the disease once and for all. The joint funding package
announced by the Scottish Government today is another vital step in
that direction, and we are extremely grateful to the Cabinet
Secretary and the Government for backing men in this way.
"Working together with the Government and the people of Scotland
we can, and will, beat prostate cancer."